In Brief This Week: RainDance, Thermo Fisher Scientific, and Celera | GenomeWeb

NEW YORK (GenomeWeb News) – RainDance Technologies said this week that it has made the first commercial shipment of its RDT 1000 and Sequence Enrichment Solution. The Lexington, Mass.-based firm said that it had shipped the RDT 1000, consumables kits, and custom PCR prime libraries to the Ontario Institute for cancer Research, which will use the products in its discovery and validation of DNA sequence variants associated with cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.